Real-world Omalizumab and Mepolizumab Treated Difficult Asthma Phenotypes and Their Clinical Outcomes

被引：0
|
作者：
Fong, W. C. G.
Azim, A.
Knight, D.
机构：
来源：
PEDIATRICS | 2021年 / 148卷
关键词：
D O I：
10.1542/peds.2021-053843RRRR
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 50 条
  • [1] Real-world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes
    Fong, Wei Chern Gavin
    Azim, Adnan
    Knight, Deborah
    Mistry, Heena
    Freeman, Anna
    Felongco, Mae
    Kyyaly, Aref
    Harvey, Matthew
    Dennison, Patrick
    Zhang, Hongmei
    Howarth, Peter
    Arshad, Syed Hasan
    Kurukulaaratchy, Ramesh J.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (08): : 1019 - 1032
  • [2] Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
    Fong, Wei Chern Gavin
    Azim, Adnan
    Knight, Deborah
    Mistry, Heena
    Freeman, Anna
    Felongco, Mae
    Kyyaly, Aref
    Harvey, Matthew
    Dennison, Paddy
    Zhang, Hongmei
    Howarth, Peter
    Arshad, Syed Hasan
    Kurukulaaratchy, Ramesh
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Severe asthma phenotypes in patients controlled with omalizumab: A real-world study
    Campo, Paloma
    Soto Campos, Gregorio
    Blanco Aparicio, Marina
    Moreira Jorge, Ana
    Gonzalez Exposito, Hector Manuel
    Quirce, Santiago
    Davila, Ignacio
    [J]. RESPIRATORY MEDICINE, 2019, 159
  • [4] Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
    Walsh, Laura J.
    Casey, Deborah
    Vairamani, Punitha
    Arnott, Fiona
    Plant, Barry J.
    Murphy, Desmond M.
    [J]. FRONTIERS IN ALLERGY, 2023, 3
  • [5] A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S53
  • [6] A REAL-WORLD ASSESSMENT OF OMALIZUMAB TREATMENT PATTERNS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
  • [7] Real-World Clinical Outcomes of Asthma patients switched from Reslizumab to either Mepolizumab or Benralizumab
    Walsh, Laura J.
    Casey, Deborah
    Vairamani, Punitha
    Arnott, Fiona
    Plant, Barry J.
    Murphy, Desmond M.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S138 - S138
  • [8] Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma
    Kavati, Abhishek
    Zhdanava, Maryia
    Ortiz, Benjamin
    Lecocq, Jason
    Schiffman, Bradd
    Pilon, Dominic
    Ho, Harriet
    Lefebvre, Patrick
    Stone, Brian
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (10) : 1956 - 1971
  • [9] Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab
    Ke, Xuehua
    Kavati, Abhishek
    Wertz, Debra
    Huang, Qing
    Wang, Liya
    Willey, Vincent J.
    Stephenson, Judith J.
    Ortiz, Benjamin
    Panettieri, Reynold A., Jr.
    Corren, Jonathan
    [J]. CLINICAL THERAPEUTICS, 2018, 40 (07) : 1140 - 1158
  • [10] Real-World Effectiveness of Mepolizumab in an Academic Asthma Clinic
    Sharma, P.
    Vitari, C. A.
    Tuft, M.
    Wenzel, S. E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345